Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)

ClinicalTrials.gov ID: NCT05005845

Public ClinicalTrials.gov record NCT05005845. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 2:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Phase 2 Dose-Response Study to Determine Safety and Effectiveness of Two Concentrations of NFX-179 Gel in Subjects With Cutaneous Neurofibromas

Study identification

NCT ID
NCT05005845
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
NFlection Therapeutics, Inc.
Industry
Enrollment
199 participants

Conditions and interventions

Interventions

  • NFX-179 gel Drug
  • Vehicle gel Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 28, 2021
Primary completion
Oct 1, 2023
Completion
Oct 1, 2023
Last update posted
Feb 16, 2026

2021 – 2023

United States locations

U.S. sites
23
U.S. states
18
U.S. cities
23
Facility City State ZIP Site status
University of Arkansas for Medical Sciences Little Rock Arkansas 72205-7199
Northwest Arkansas Clinical Trials Center, PLLC Rogers Arkansas 72758
Center for Dermatology Clinical Research, Inc. Fremont California 94538
Children's Hospital Los Angeles Los Angeles California 90027
University Clinical Trials, Inc. San Diego California 92123
Children's National Hospital Washington D.C. District of Columbia 20010
University of Florida Gainesville Florida 32610
Northshore University HealthSystem Evanston Illinois 60077
Dawes Fretzin Clinical Research Group Indianapolis Indiana 46250
The Johns Hopkins School of Medicine Baltimore Maryland 21287
Massachusetts General Hospital Boston Massachusetts 02114
Minnesota Clinical Study Center New Brighton Minnesota 55112
Skin Specialists, P.C. Omaha Nebraska 68144
Sadick Research Group, LLC New York New York 10075
Skin Search of Rochester, Inc. Rochester New York 14623
Wake Forest School of Medicine Winston-Salem North Carolina 27157
Apex Clinical Research Center, LLC Mayfield Heights Ohio 44124
Oregon Health & Science University Portland Oregon 97239
Derm Dox Center for Dermatology Sugarloaf Pennsylvania 18249
Dermatology Treatment and Research Center Dallas Texas 75230
UTHealth McGovern Medical School Houston Texas 77030
University of Utah Salt Lake City Utah 84108
The Education & Research Foundation, Inc. Lynchburg Virginia 24501

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05005845, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 16, 2026 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05005845 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →